>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
94例甲状腺微小乳头状癌颈部淋巴结转移的影响因素分析
作者:廖帅举  刘晓丽  倪卫惠  陈晨  王全胜 
单位:南京医科大学附属明基医院 内分泌科, 江苏 南京 210019
关键词:甲状腺微小乳头状癌 颈部淋巴结转移 中央区淋巴结转移 危险因素 
分类号:R736.1
出版年·卷·期(页码):2022·41·第一期(132-137)
摘要:

目的:回顾性研究甲状腺微小乳头状癌颈部淋巴结以及颈部中央区淋巴结转移的相关影响因素。方法:收集2019年1月至2021年5月南京医科大学附属明基医院收治的94例甲状腺微小乳头状癌患者的临床资料,分析其性别、年龄、肿瘤数量、肿瘤位置、多灶性、被膜侵犯、血流信号、肿瘤侧别、肿瘤钙化、肿瘤纵横比、促甲状腺素激素、淋巴细胞性甲状腺炎、患者文化程度、病程与颈部淋巴结、颈部中央区淋巴结转移的相关性。结果:颈部淋巴结转移率为47%(44/94),经单因素分析,性别、年龄、被膜侵犯是甲状腺微小乳头状癌颈部淋巴结转移的危险因素(P<0.05);Logistic回归分析结果显示,男性和被膜侵犯是甲状腺微小乳头状癌颈部淋巴结转移的危险因素(P<0.05)。颈部中央区淋巴结转移率为33%(31/94),经单因素分析,性别、被膜侵犯是甲状腺微小乳头状癌颈部中央区淋巴结转移的危险因素(P<0.05);Logistic回归分析结果显示,男性和被膜侵犯是甲状腺微小乳头状癌颈部中央区淋巴结转移的危险因素(P<0.05)。结论:建议对有被膜侵犯的男性甲状腺微小乳头状癌患者进行预防性淋巴结清扫,降低因肿瘤复发而行再次手术的风险。

Objective: A retrospective study was conducted on the factors influencing cervical lymph node metastasis and central lymph node metastasis of papillary thyroid microcarcinoma. Methods: Clinical data of 94 patients with papillary thyroid microcarcinoma admitted to the Affiliated BenQ Hospital of Nanjing Medical University from January 2019 to May 2021 were collected.The correlations between gender, age, tumor number, tumor location, multifocal, capsule invasion, blood flow signal, tumor side, tumor calcification, tumor aspect ratio, thyrotropin hormone, lymphocytic thyroiditis, degree of education, course of the disease, cervical lymph node metastasis and central lymph node metastasis were analyzed. Results: The rate of cervical lymph node metastasis was 47%(44/94). According to univariate analysis, sex, age and capsular invasion were risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma(P<0.05). Logistic regression analysis showed that male and capsular invasion were risk factors for cervical lymph node metastasis of papillary thyroid microcarcinoma(P<0.05).The rate of cervical central lymph node metastasis was 33%(31/94).Univariate analysis showed that gender and capsular invasion were risk factors for cervical central lymph node metastasis of papillary thyroid microcarcinoma(P<0.05).Logistic regression analysis showed that male and capsular invasion were risk factors for cervical central lymph node metastasis of papillary thyroid microcarcinoma(P<0.05).Conclusion: Prophylactic lymph node dissection is recommended for male patients with papillary thyroid microcarcinoma with capsule invasion to reduce the risk of reoperation due to tumor recurrence.

参考文献:

[1] XIA S, JI R, ZHAN W.Long noncoding RNA papillary thyroid carcinoma susceptibility candidate 3(PTCSC3) inhibits proliferation and invasion of glioma cells by suppressing the Wnt/β-catenin signaling pathway[J].BMC Neurology, 2017, 17(1):30.
[2] HWDINGER C, WILLIAMS E D, SOBIN L H.The WHO histo-logical classification of thyroid tumors:a commentary on the second edition[J].Cancer, 1989, 63(5):908-911.
[3] CHO S Y, LEE T H, KU Y H, et al.Central lymph node metastasis inpapillary thyroid microcarcinoma can be stratified according to the number, the size of metastatic foci, and the presence of desmoplasia[J].Surgery, 2015, 157(1):111-118.
[4] 王岩岩, 李莉, 彭德峰, 等.甲状腺微小乳头状癌中央区淋巴结转移的相关因素分析[J].中华全科医学, 2018, 16(8):1268-1270, 1282.
[5] HAUGEN B R, ALEXANDER E K, BIBLE K C, et al.2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer:the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer[J].Thyroid, 2016, 26(1):1-133.
[6] 中国抗癌协会甲状腺癌专业委员会.甲状腺微小乳头状癌诊断与治疗中国专家共识(2016版)[J].中国肿瘤临床, 2016, 43(10):405-411.
[7] QU H, SUN G R, LIU Y, et al.Clinical risk factors for central lymph node metastasis in papillary thyroid carcinoma:a systematic review and meta -analysis[J].Clin Endocrinol, 2015, 83(1):124-132.
[8] SO Y K, KIM M J, KIM S, et al.Lateral lymph node metastasis in papillary thyroid carcinoma:a systematic review and meta-analysis for prevalence, risk factors, and location[J].International Journal of Surgery, 2018, 50:94-103.
[9] LEE J, SONG Y, SOH E Y.Central lymph node metastasis is an important prognostic factor in patients with papillary thyroid microcarcinoma[J].J Korean Med Sci, 2014, 29(1):48-52.
[10] ERDEM H, GUNDOGDU C, SIPAL S.Correlation of E-cadherin, VEGF, COX-2 expression to prognostic parameters in papillary thyroid carcinoma[J].Exp Mol Pathol, 2011, 90(3):312-317.
[11] ZHOU Y L, GAO E L, ZHANG W, et al.Factors predictive of papillary thyroid micro-carcinoma with bilateral involvement and central lymph node metastasis:a retrospective study[J].World J Surg Oncol, 2012, 10:67.
[12] YANG Y, CHEN C, CHEN Z, et al.Prediction of central compartment lymph node metastasis in papillary thyroid microcarcinoma[J].Clin Endocrinol, 2014, 81(2):282-288.
[13] 张于芝, 丁文波, 武心萍, 等.临床超声及细胞病理学特征对甲状腺微小乳头状癌中央区淋巴结转移的预测价值[J].中国超声医学杂志, 2017, 33(11):964-967.
[14] 樊秋兰, 陈霰, 于春洋, 等.普通超声及超声造影预测甲状腺微小乳头状癌中央区淋巴结转移的价值[J].中国超声医学杂志, 2016, 32(12):1060-1062.
[15] 马亚辉, 刘宜翔, 易国华, 等.cN0期甲状腺微小乳头状癌颈侧区淋巴结转移的危险因素及预防性清扫的临床分析[J].国际外科学杂志, 2019, 46(4):242-246.
[16] 姜波, 罗渝昆, 张艳, 等.甲状腺乳头状癌的常规超声及超声造影特征与淋巴结转移的相关性[J].首都医科大学学报, 2019, 40(6):818-823.
[17] 王文涵, 詹维伟, 徐上妍, 等.甲状腺微小乳头状癌的超声特征与颈部淋巴结转移的关系[J].中华超声影像学杂志, 2014, 23(3):231-234.
[18] 庄欢, 廉猛, 房居高, 等.cN0甲状腺微小乳头状癌中央区淋巴结转移相关因素分析[J].中国耳鼻咽喉头颈外科, 2020, 27(6):311-315.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 414208 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364